Winner Medical(SZ:300888) Sou Hu Cai Jing·2025-07-31 12:48Core Viewpoint - The stock of Steady Medical (300888) has experienced a decline, with significant net outflows from major funds, indicating potential concerns among institutional investors [1][2]. Financial Performance - As of July 31, 2025, Steady Medical's stock closed at 40.00 yuan, down 2.32%, with a trading volume of 67,000 hands and a transaction amount of 270 million yuan [1]. - The company reported a main revenue of 2.605 billion yuan for Q1 2025, a year-on-year increase of 36.47%, and a net profit attributable to shareholders of 249 million yuan, also up 36.26% year-on-year [3]. - The company's gross profit margin stands at 48.46%, which is higher than the industry average of 42.27% [3]. Market Position - Steady Medical has a total market value of 23.293 billion yuan, ranking 4th in the beauty and personal care industry, with a net asset value of 12.146 billion yuan, ranking 1st [3]. - The company's price-to-earnings ratio (P/E) is 23.43, which is lower than the industry average of 39.83, indicating a potentially undervalued stock [3]. Fund Flow Analysis - On July 31, 2025, the net outflow of major funds was 27.4298 million yuan, accounting for 10.15% of the total transaction amount, while retail investors saw a net inflow of 7.5146 million yuan, representing 2.78% of the total [1][2]. - Over the past five days, the stock has seen fluctuating fund flows, with significant net outflows from major funds on multiple days [2]. Institutional Ratings - In the last 90 days, 23 institutions have rated the stock, with 19 buy ratings and 4 hold ratings, indicating a generally positive outlook among analysts [4]. - The average target price set by institutions over the past 90 days is 58.04 yuan, suggesting potential upside from the current trading price [4].